McKesson to Buy Stake in Florida Cancer Chain for $2.49 Billion.

McKesson Corp. has agreed to purchase a controlling stake in Core Ventures, a subsidiary of Florida Cancer Specialists & Research Institute, for $2.49 billion in cash. Core Ventures is a business and administrative services organization established by Florida Cancer Specialists, with the physicians retaining a minority interest in the subsidiary. McKesson and its competitors have been expanding their services in the field of cancer care to enhance the distribution of specialty drugs. Florida Cancer Specialists, founded 40 years ago, has over 250 physicians, 280 nurse practitioners and physician assistants, and approximately 100 locations in its network. The company specializes in value-based oncology care, where the provider assumes some or all of the treatment costs in exchange for a lump sum from a healthcare payer. [Extracted from the article]